Use caution Medical device recall · FDA · Published April 24, 2026

Bayer Avanta Tube Sets: Stopcock Disengagement Risk During Contrast Injection

Bayer recalls Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT) used with Medrad Avanta Injection due to stopcock disengagement risk during contrast injection. Affected units have specific catalog and batch numbers.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-2296-2026Medical device Bayer ›

Use caution until it’s fixed

Supplier changes resulted in a fit issue with the Contrast Flow Control Valve (CFCV) interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface. In instances where engagement is achieved through applied force, the connection is unstable, and the stopcock may disengage before or during contrast injection, leading to procedure interruption.

Take action

Contact the company

Recalling firmBayer Medical Care, Inc.1 Bayer Dr · Indianola, PA 15051-9702

✎ GovInfoNow plain-language explainer

Bayer is recalling Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT) used with Medrad Avanta Injection systems because the stopcock may disengage during contrast injection, causing procedure interruptions. This risk affects medical professionals using these tubes in imaging procedures. Read more at govinfonow.com/recall/49380-bayer-avanta-tube-sets-stopcock-disengagement-risk-during-contrast-injection.

Source Summary by GovInfoNow · govinfonow.com/recall/49380-bayer-avanta-tube-sets-stopcock-disengagement-risk-during-contrast-injection · Updated August 17, 2026 · FDA enforcement record: FDA #Z-2296-2026

Cite this page

“Bayer Avanta Tube Sets: Stopcock Disengagement Risk During Contrast Injection.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49380-bayer-avanta-tube-sets-stopcock-disengagement-risk-during-contrast-injection. Based on FDA recall #Z-2296-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2296-2026%22&limit=1).

Bayer Medical Care, Inc. recalled Avanta Multi-Patient Administration Tube Sets on April 24, 2026, due to a fit issue that may cause the stopcock to disengage during use, according to the FDA. The agency announced the Class II recall of 11,300 units distributed worldwide.

How to tell if you have it

Brand: Bayer
Product: Avanta Multi-Patient Administration Tube Sets (AVA 500 MPAT (Part 2 of 2))
Catalog number: AVA 500 MPAT (Part 2 of 2)
Affected material numbers: 87629007, 60729458, 86566648
Affected batch numbers: 251702, 252302, 252502, 252602, 252702, 252802, 253304, 253702, 253704, 253804, 254202, 254304, 254704, 254802

The hazard

Supplier changes resulted in a fit issue with the Contrast Flow Control Valve interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface, and if forced, the connection is unstable, potentially leading to procedure interruption.

Context

GovInfoNow's records show Bayer Medical Care, Inc. has had 7 other recalls since June 28, 2018. Recent brand recalls include a July 31, 2026 sterilization issue with Stellant FLEX Syringe Kits and an Nov. 30, 2022 labeling error for Source Administration Sets. Other recent recalls of similar products include a Nov. 26, 2025 Medline kit recall involving stuck check valves and an April 3, 2026 Elekta applicator set recall regarding tube detachment risk.

How to tell if you have this one

Check for catalog number AVA 500 MPAT (Part 2 of 2) and affected batch numbers: 251702, 252302, 252502, 252602, 252702, 252802, 253304, 253702, 253704, 253804, 254202, 254304, 254704, 254802.

Brand
Bayer
Category
Medical device

Based on the official FDA remedy

What to do — step by step

Check for Affected Units
Look for catalog number AVA 500 MPAT (Part 2 of 2) and affected batch numbers listed in the recall notice.
Use Alternative Tubes
If you have affected units, switch to a different tube set that is not recalled to avoid disengagement risks.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 27 states.

FDA distribution: “Worldwide - US Nationwide distribution including in the states of AL, AR, AZ, CA, CO, DE, FL, IA, IL, IN, KS, KY, LA, MA, MD, ME, MO, NC, NY, OH, OK, PA, SC, TN, TX, VA, WI and the countries of AE, BA, BE, CA, CH, CN, DE, DK, ES, FR, GB,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, Arkansas, California, Colorado, Delaware, Florida, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Missouri, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, Wisconsin.

Recall timeline

FDA published this recall 47 days after the firm started it.

Apr 24, 2026Firm started the recall
Jun 3, 2026FDA classified it Class II
Jun 10, 2026Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

More Bayer recalls

Link to this recall

<a href="https://govinfonow.com/recall/49380-bayer-avanta-tube-sets-stopcock-disengagement-risk-during-contrast-injection">Bayer Avanta Tube Sets: Stopcock Disengagement Risk During Contrast Injection (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #Z-2296-2026 (April 24, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2296-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.